BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 903141)

  • 1. Squamous cell neoplasia controversy in the female exposed to diethylstilbestrol.
    Robboy SJ; Prat J; Welch WR; Barnes AB
    Hum Pathol; 1977 Sep; 8(5):483-5. PubMed ID: 903141
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosquamous carcinoma of the cervix in a woman exposed to diethylstilbestrol in utero.
    Vandrie DM; Puri S; Upton RT; DeMeester LJ
    Obstet Gynecol; 1983 Mar; 61(3 Suppl):84S-87S. PubMed ID: 6823400
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaginal and cervical squamous cell dysplasia in women exposed to diethylstilbestrol in utero.
    Burke L; Antonioli D; Rosen S
    Am J Obstet Gynecol; 1978 Nov; 132(5):537-44. PubMed ID: 717453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol.
    Robboy SJ; Keh PC; Nickerson RJ; Helmanis EK; Prat J; Szyfelbein WM; Taft PD; Barnes AB; Scully RE; Welch WR
    Obstet Gynecol; 1978 May; 51(5):528-35. PubMed ID: 652199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia.
    Robboy SJ; Truslow GY; Anton J; Richart RM
    Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S98-110. PubMed ID: 7030882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
    Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
    Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear DNA study of vaginal and cervical squamous cell abnormalities in DES exposed progeny.
    Fu YS; Robboy SJ; Prat J
    Obstet Gynecol; 1978 Aug; 52(2):129-37. PubMed ID: 683651
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project.
    Robboy SJ; Noller KL; O'Brien P; Kaufman RH; Townsend D; Barnes AB; Gundersen J; Lawrence WD; Bergstrahl E; McGorray S
    JAMA; 1984 Dec; 252(21):2979-83. PubMed ID: 6502858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical intraepithelial neoplasia associated with exposure to diethylstilbestrol in utero: a clinical and pathologic study.
    Orr JW; Shingleton HM; Gore H; Austin JM; Hatch KD; Soong SJ
    Obstet Gynecol; 1981 Jul; 58(1):75-82. PubMed ID: 7195532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis and treatment of cervix dysplasia].
    Höffken H
    Med Welt; 1980 Sep; 31(39):1388-90. PubMed ID: 7453522
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the abnormal Pap smear.
    Homesley HD
    Am Fam Physician; 1977 Sep; 16(3):190-4. PubMed ID: 900003
    [No Abstract]   [Full Text] [Related]  

  • 12. Cervical cancer--intraepithelial neoplasia, severe dysplasia, invasive cancer of cervix, DES exposure.
    Fowler W
    Proc Annu Meet Med Sect Am Counc Life Insur; 1982; ():73-85. PubMed ID: 7184030
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytologic and histologic diagnosis and significance of controversial squamous lesions of the uterine cervix.
    Duggan MA
    Mod Pathol; 2000 Mar; 13(3):252-60. PubMed ID: 10757336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure.
    Veridiano NP; Tancer ML; Weiner EA
    Obstet Gynecol; 1978 Jul; 52(1 Suppl):30S-33S. PubMed ID: 683639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Argyrophilic proteins in the nucleolar organizer in the differential diagnosis of cervical dysplasias and cancer].
    Diadyk EA; Vasilenko IV; Smirnova EA; Raĭkhlin NT
    Arkh Patol; 1993; 55(2):23-7. PubMed ID: 7980057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Refocusing on the gynecological and obstetrical consequences of intrauterine exposure to diethylstilbestrol (DES)].
    Verheijen RH; Schijf CP; van Dongen PW; van der Zanden PH; Bakker EH
    Ned Tijdschr Geneeskd; 1991 Jan; 135(3):89-93. PubMed ID: 1996166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Difficulties in the detection and the diagnosis of carcinoma in situ of the uterine cervix in the presence of associated dysplasia].
    Dargent D; Bremond A; Rudigoz RG; Beau GE
    Nouv Presse Med; 1976 Nov; 5(40):2691-3. PubMed ID: 1005084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histochemical methods in the diagnosis of precancerous states and early forms of cancer of the uterine cervix.
    Yakovleva IA; Kukute BG
    Folia Histochem Cytochem (Krakow); 1976; 14(4):243-7. PubMed ID: 192643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diethylstilbestrol (DES) update. A message from the DESAD Project.
    Powers D
    Wis Med J; 1985 Feb; 84(2):11-4. PubMed ID: 3984375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.